Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer

In recent years, translational research and pharmacological targeting of epigenetic modifications have become the focus of personalized therapy for patients with pancreatic cancer. Preclinical and clinical trials targeting post-translational modifications have been evaluated as monotherapy or in com...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hui-Ching, Shih, Hsiang-Yao, Wu, Chun-Chieh, Chen, Li-Tzong, Luo, Chi-Wen, Liu, Yi-Chang, Du, Jeng-Shiun, Huang, Min-Chin, Su, Yung-Yeh, Chen, Huan-Da, Hsiao, Hui-Hua, Moi, Sin-Hua, Pan, Mei-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515693/
https://www.ncbi.nlm.nih.gov/pubmed/36185333
http://dx.doi.org/10.7150/ijms.73800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515693/
https://www.ncbi.nlm.nih.gov/pubmed/36185333
http://dx.doi.org/10.7150/ijms.73800

Ejemplares similares